Abstract:In the recent era, scientific interest has been piqued by Helicobacter pylori , a bacterium that resides in the human stomach and has been linked to a range of gastrointestinal disorders including gastritis, peptic ulcers, and an increased risk of gastric cancer. In this study, we conducted synthesis, characterization, DFT-based investigations, and in silico biological assessments of three novel dipeptide-sulphonamide derivatives to evaluate their potential as drug candidates targeting H. pylori receptors. The results of the vibrational energy distribution study were compared to the experimental vibrational frequencies, and they were found to be in good agreement. Investigation of intramolecular charge transfer interactions and stabilization energies was conducted through natural bond orbital (NBO) analysis. The analysis revealed a range of stabilization energies, with compound C exhibiting the highest energy of 657.15 kcal/mol, followed by compound A at 448.97 kcal/mol, and compound B at 418.97 kcal/mol. This order of stability correlates with their reactivity, as evidenced by energy values of 7.6693 eV for compound C, 8.4154 eV for compound A, and 8.9295 eV for compound B. These findings suggest that compound C is the most reactive among the studied species. The molecular docking results revealed that the ligands; N -(2-(Isobutylamino)-2-oxoethyl)-3-methyl-2-(4-methylphenylsulphonamido) pentanamide (A ), N -(2-(Isobutylamino)-2-oxoethyl)-3-methyl-2-(phenylsulphonamido) pentanamide (B), and N- (2(Isobutylamino)2-oxoethyl)3-methyl-2(4-nitrophenylsulphonamido) pentanamide (C) exhibited excellent selectivity and reactivity with the protein 2QV3 compared to the standard lansoprazole. The findings clearly show that these novel dipeptide-sulphonamides could represent a new class of potential anti-ulcer agents and, with further research, could be used as new anti-ulcer medications.

Cyclization of acyl thiosemicarbazides led to new Helicobacter pylori α‐carbonic anhydrase inhibitors

Azobenzenesulfonamide Carbonic Anhydrase Inhibitors as New Weapons to Fight Helicobacter pylori: Synthesis, Bioactivity Evaluation, In Vivo Toxicity, and Computational Studies

Selective Inhibition of Helicobacter pylori Carbonic Anhydrases by Carvacrol and Thymol Could Impair Biofilm Production and the Release of Outer Membrane Vesicles

Three flavonoids targeting the β-hydroxyacyl-acyl carrier protein dehydratase from Helicobacter pylori: Crystal structure characterization with enzymatic inhibition assay

Helicobacter pylori CAs inhibition

Carbonic Anhydrases: New Perspectives on Protein Functional Role and Inhibition in Helicobacter pylori

Discovery of Cinnamic Acid Derivatives as Potent Anti-H. pylori Agents

Design and synthesis of novel anti-urease imidazothiazole derivatives with promising antibacterial activity against Helicobacter pylori

Novel carbonic anhydrase inhibitors for the treatment of Helicobacter pylori infection

In vitro anti- Helicobacter pylori , anti-urease and anti-gastric cancer activities of novel hydrazones

Synthesis, characterization, DFT studies, and in silico biological evaluation of novel dipeptide-sulphonamide derivatives against Helicobacter pylori receptors

Benzimidazole derivatives: A versatile scaffold for drug development against Helicobacter pylori‐related diseases

Design and discovery of urease and Helicobacter pylori inhibitors based on benzofuran/benzothiophene-sulfonate and sulfamate scaffolds for the treatment of ureolytic bacterial infections

Novel Drug-like HsrA Inhibitors Exhibit Potent Narrow-Spectrum Antimicrobial Activities against Helicobacter pylori

Discovering potent inhibitors against the β-hydroxyacyl-acyl carrier protein dehydratase (FabZ) of helicobacter pylori: Structure-based design, synthesis, bioassay, and crystal structure determination

Synthesis, molecular docking and biological evaluation of metronidazole derivatives as potent Helicobacter pylori urease inhibitors.

Arylamino Containing Hydroxamic Acids As Potent Urease Inhibitors for the Treatment of Helicobacter Pylori Infection.

Synthesis, molecular docking and biological evaluation of 3-arylfuran-2(5H)-ones as anti-gastric ulcer agent

Synthesis and Biological Evaluation of Dithiobisacetamides as Novel Urease Inhibitors

Synthesis, DFT, and in silico biological evaluation of chalcone bearing pyrazoline ring against Helicobacter pylori receptors

Molecular design of hydroxamic acid-based derivatives as urease inhibitors of Helicobacter pylori